Literature DB >> 27637783

A Perspective on the Nature and Frequency of Pigment Epithelial Detachments.

Anna C S Tan1, Daniel Simhaee2, Chandrakumar Balaratnasingam3, Kunal K Dansingani4, Lawrence A Yannuzzi5.   

Abstract

PURPOSE: To describe and compare the clinical and imaging characteristics of pigment epithelial detachments (PEDs) in age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), and central serous chorioretinopathy (CSC) as seen in a clinical setting of a tertiary retinal practice.
DESIGN: A perspective supported by clinical and imaging characteristics of a consecutive cohort of patients with strictly defined PEDs.
RESULTS: One hundred seventy-four eyes of 113 patients with PEDs were studied with comprehensive clinical retinal examination and multimodal imaging; PEDs were differentiated into nonvascularized and vascularized forms with 3 main underlying etiologies: AMD (76%), PCV (9%), and CSC (3%). AMD was the most common diagnosis, with both nonvascularized PEDs (drusenoid and serous) and vascularized PEDs (type 1 and type 3 neovascularization) associated with drusen and a thin choroid. PCV patients had large, vascularized, peaked PEDs associated with polyps and a variable choroidal thickness, while CSC patients had a thick choroid and predominantly nonvascularized, serous PEDs with an overlying neurosensory detachment. The combined clinical and imaging characteristics form a profile for each PED subtype related to their underlying disease. However, atypical features noted in 11% of patients may complicate the underlying diagnosis.
CONCLUSION: Typical phenotypic manifestations of PEDs and other features seen with multimodal imaging were associated with specific underlying etiologies. As suggested by our study, identification of these features help clinicians to determine the precise underlying etiology and manage both vascularized PEDs, where evidence-based treatment exists, and nonvascularized PEDs, where current treatment is not supported by convincing evidence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27637783     DOI: 10.1016/j.ajo.2016.09.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy.

Authors:  Claudio Iovino; Jay Chhablani; Deepika C Parameswarappa; Marco Pellegrini; Giuseppe Giannaccare; Enrico Peiretti
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

2.  Dual-stage deep learning framework for pigment epithelium detachment segmentation in polypoidal choroidal vasculopathy.

Authors:  Yupeng Xu; Ke Yan; Jinman Kim; Xiuying Wang; Changyang Li; Li Su; Suqin Yu; Xun Xu; Dagan David Feng
Journal:  Biomed Opt Express       Date:  2017-08-10       Impact factor: 3.732

3.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Kai Xiong Cheong; Dilraj Singh Grewal; Kelvin Yi Chong Teo; Alfred Tau Liang Gan; Glenn Jay Jaffe; Gemmy Chui Ming Cheung
Journal:  Eye (Lond)       Date:  2020-02-11       Impact factor: 3.775

5.  Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?

Authors:  Yuwei Wang; Qiyu Bo; Huixun Jia; Mengsha Sun; Yang Yu; Peirong Huang; Jing Wang; Nana Xu; Fenghua Wang; Hong Wang; Xiaodong Sun
Journal:  Eye (Lond)       Date:  2021-04-08       Impact factor: 3.775

6.  Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment.

Authors:  Taiyo Shijo; Yoichi Sakurada; Koji Tanaka; Akiko Miki; Atsushi Sugiyama; Hajime Onoe; Aya Chubachi; Wataru Kikushima; Yu Wakatsuki; Seigo Yoneyama; Ryusaburo Mori; Kenji Kashiwagi
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

7.  Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report.

Authors:  Marlene Saßmannshausen; Charlotte Behning; Ben Isselmann; Matthias Schmid; Robert P Finger; Frank G Holz; Steffen Schmitz-Valckenberg; Maximilian Pfau; Sarah Thiele
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

Review 8.  An overview of the clinical applications of optical coherence tomography angiography.

Authors:  A C S Tan; G S Tan; A K Denniston; P A Keane; M Ang; D Milea; U Chakravarthy; C M G Cheung
Journal:  Eye (Lond)       Date:  2017-09-08       Impact factor: 3.775

Review 9.  Management of chronic central serous chorioretinopathy.

Authors:  Daren Hanumunthadu; Anna C S Tan; Sumit Randhir Singh; Niroj Kumar Sahu; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

10.  Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression.

Authors:  Sarah Thiele; Jennifer Nadal; Maximilian Pfau; Marlene Saßmannshausen; Monika Fleckenstein; Frank G Holz; Matthias Schmid; Steffen Schmitz-Valckenberg
Journal:  Br J Ophthalmol       Date:  2020-04-08       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.